Cargando…

Evaluation of the Receptor Activator of Nuclear Factor Kappa B Ligand (RANKL) Expression in Osteosarcoma and Its Association with the Clinicopathological Data

BACKGROUND: The receptor activator of nuclear factor kappa B ligand (RANKL) is one of the key regulators of bone remodelling in bone oncology, including osteosarcoma. We assessed RANKL immunohistochemical expression in osteosarcoma, its association, and disease-free survival with the patients’ clini...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chua, Hui Heng, Tuan Sharif, Sharifah Emilia, Wan Ismail, Wan Faisham Nu’man, Zawawi, Muhamad Syahrul Fitri, Abdullah, Sarimah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	West Asia Organization for Cancer Prevention 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286667/ https://www.ncbi.nlm.nih.gov/pubmed/33773537 http://dx.doi.org/10.31557/APJCP.2021.22.3.741

Ejemplares similares

The Values of Receptor Activator Nuclear Kappa-B Ligand Expression in Stage III Giant Cell Tumor of the Bone
por: Ghani, Sabrina Abdul, et al.
Publicado: (2018)

The Value of H3K27me3 Immunohistochemistry in Differentiating Malignant Peripheral Nerve Sheath Tumour with Its Histologic Mimickers
por: Mustapar, Nurulhasanah, et al.
Publicado: (2020)

Desmoplastic Fibroma of the Phalanx of the Hand: A Rare Case Report
por: Singh, Belzinder Pal, et al.
Publicado: (2023)

Genesis and Symptom Interval of Osteosarcoma Following High-Energy Trauma
por: Sharifudin, Mohd Ariff, et al.
Publicado: (2021)

Massage manipulation and progression of osteosarcoma, does it really correlate: a combination of prospective and retrospective cohort study
por: Karda, I Wayan Arya Mahendra, et al.
Publicado: (2023)

Effect of Cornus Officinalis on Receptor Activator of Nuclear Factor-kappaB Ligand (RANKL)-induced Osteoclast Differentiation
por: Kim, Jung Young, et al.
Publicado: (2012)

Successful ankle replantation in two cases with different presentations
por: Wen, Adzim Poh Yuen, et al.
Publicado: (2020)

A Critical Appraisal of COVID-19 in Malaysia and Beyond
por: Abdullah, Jafri Malin, et al.
Publicado: (2020)

Changes in Metabolism and Mitochondrial Bioenergetics during Polyethylene-Induced Osteoclastogenesis
por: Mohamad Hazir, Nur Shukriyah, et al.
Publicado: (2022)

Receptor activator of NF-kappaB ligand (RANKL) and CD 31 expressions in chronic periodontitis patients before and after surgery
por: Friedmann, Anton, et al.
Publicado: (2014)

Receptor activator of nuclear factor kappa-B ligand (RANKL) but not sclerostin or gene polymorphisms is related to joint destruction in early rheumatoid arthritis
por: Boman, Antonia, et al.
Publicado: (2017)

α-Tocopheryl Succinate Inhibits Osteoclast Formation by Suppressing Receptor Activator of Nuclear Factor-kappaB Ligand (RANKL) Expression and Bone Resorption
por: Kim, Ha-Neui, et al.
Publicado: (2012)

Enhancement of Scaffold In Vivo Biodegradability for Bone Regeneration Using P28 Peptide Formulations
por: Azaman, Farah Alwani, et al.
Publicado: (2023)

Potential role and mechanism of IFN-gamma inducible protein-10 on receptor activator of nuclear factor kappa-B ligand (RANKL) expression in rheumatoid arthritis
por: Lee, Eun Young, et al.
Publicado: (2011)

CCAAT/enhancer-binding protein β promotes receptor activator of nuclear factor-kappa-B ligand (RANKL) expression and osteoclast formation in the synovium in rheumatoid arthritis
por: Tsushima, Hidetoshi, et al.
Publicado: (2015)

Eleutherococcus sessiliflorus Inhibits Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL)-Induced Osteoclast Differentiation and Prevents Ovariectomy (OVX)-Induced Bone Loss
por: Han, Sang-Yong, et al.
Publicado: (2021)

Yukmijihwang-Tang Suppresses Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL)-Induced Osteoclast Differentiation and Prevents Ovariectomy (OVX)-Mediated Bone Loss
por: Han, Sang-Yong, et al.
Publicado: (2021)

Effects of Lactobacillus reuteri MG5346 on Receptor Activator of Nuclear Factor-Kappa B Ligand (RANKL)-Induced Osteoclastogenesis and Ligature-Induced Experimental Periodontitis Rats
por: Jeong, Yu-Jin, et al.
Publicado: (2023)

Exenatide can inhibit calcification of human VSMCs through the NF-kappaB/RANKL signaling pathway
por: Zhan, Jun-Kun, et al.
Publicado: (2014)

A case of minimal change disease after the administration of anti receptor activator of nuclear factor kappa B ligand (RANKL) monoclonal antibody: a case report
por: Horikoshi, Keisuke, et al.
Publicado: (2020)

Effect of denosumab, a human monoclonal antibody of receptor activator of nuclear factor kappa-B ligand (RANKL), upon glycemic and metabolic parameters: Effect of denosumab on glycemic parameters
por: Abe, Ichiro, et al.
Publicado: (2019)

Impact of the Rapid Normalization of Chronic Hyperglycemia on the Receptor Activator of Nuclear Factor-Kappa B Ligand and the Osteoprotegerin System in Patients Living with Type 2 Diabetes: RANKL-GLYC Study
por: Dardari, Dured, et al.
Publicado: (2022)

Expression of osteoprotegerin and its ligands, RANKL and TRAIL, in rheumatoid arthritis
por: Remuzgo-Martínez, Sara, et al.
Publicado: (2016)

Extensive plasma proteomic profiling revealed receptor activator of nuclear factor kappa-Β ligand (RANKL) as emerging biomarker of nivolumab clinical benefit in patients with metastatic renal cell carcinoma
por: Simonetti, Sonia, et al.
Publicado: (2022)

Pharmacological profiles of opioid ligands at Kappa opioid receptors
por: Gharagozlou, Parham, et al.
Publicado: (2006)

Identification of novel ligands interacting with kappa opioid receptors
por: Spetea, Mariana, et al.
Publicado: (2011)

Pharmacology of Kappa Opioid Receptors: Novel Assays and Ligands
por: Sturaro, Chiara, et al.
Publicado: (2022)

Cross-Leg Free Flap: Crossing the Border Zone of Ischemic Limb—A Case Report of Limb Salvage Procedure following a Delayed Diagnosis of Popliteal Artery Injury
por: Lam, Hui Yuan, et al.
Publicado: (2023)

Clinicopathologic Features of Membranous-Like Glomerulopathy With Masked IgG Kappa Deposits
por: Larsen, C.P., et al.
Publicado: (2016)

Breast Tumor Angiogenesis and Tumor-Associated Macrophages: Histopathologist's Perspective
por: Ch'ng, Ewe Seng, et al.
Publicado: (2011)

Outcome of Surgical Treatment of Pelvic Osteosarcoma: Hospital Universiti Sains Malaysia Experience
por: Ariff, MS, et al.
Publicado: (2013)

Administration of anti-receptor activator of nuclear factor-kappa B ligand (RANKL) antibody for the treatment of osteoporosis was associated with amelioration of hepatitis in a female patient with growth hormone deficiency: a case report
por: Takeno, Ayumu, et al.
Publicado: (2016)

The Intrinsic and Extrinsic Implications of RANKL/RANK Signaling in Osteosarcoma: From Tumor Initiation to Lung Metastases
por: Navet, Benjamin, et al.
Publicado: (2018)

A rare case of sinonasal solitary fibrous tumour in a patient with concurrent papillary thyroid carcinoma: A case report
por: Mohd Fauzi, Nurul Anis, et al.
Publicado: (2021)

Protein Profiling in Human Papillomavirus-Associated Cervical Carcinogenesis: Cornulin as a Biomarker for Disease Progression
por: Kumarasamy, Gaayathri, et al.
Publicado: (2023)

Iliac Telangiectatic Osteosarcoma - A Rare Presentation and Diagnostic Pitfall: A Case Report
por: Khaw, YC, et al.
Publicado: (2020)

RANK-ligand (RANKL) expression in young breast cancer patients and during pregnancy
por: Azim, Hatem A, et al.
Publicado: (2015)

IL-4/IL-13 Axis in Allergic Rhinitis: Elevated Serum Cytokines Levels and Inverse Association With Tight Junction Molecules Expression
por: Nur Husna, Siti Muhamad, et al.
Publicado: (2022)

Global Prevalence and Risk of Local Recurrence Following Cryosurgery of Giant Cell Tumour of Bone: A Meta-Analysis
por: Sumari, Shyful Nizam, et al.
Publicado: (2022)

Prognostic and clinicopathological significance of circulating tumor cells in osteosarcoma
por: Li, Minghui, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_i5vlu8eafj1asa0rhno963e7vh